Nirogy Therapeutics to Present at AACR Annual Meeting 2021
E-posters highlighting preclinical data demonstrate the potential of Nirogy’s small molecule therapies to enable significant activation of anti-tumor immunity and...
Staff
Terranueva Gets an Additional $500,000 in Financial Support From Canada Economic Development
L’ASSOMPTION, Quebec, April 07, 2021 (GLOBE NEWSWIRE) -- Terranueva Corporation (CSE : TEQ) (the “Corporation” or “Terranueva”), one of the 6 companies...
Rhythm Pharmaceuticals to Present at 20th Annual Needham Virtual Healthcare Conference
BOSTON, April 07, 2021 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed at developing and commercializing...
ImmuCell Announces Preliminary, Unaudited Sales Results for First Quarter of 2021
PORTLAND, Maine, April 07, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company...
X4 Pharmaceuticals to Present at the 20th Annual Needham Virtual Healthcare Conference
BOSTON, April 07, 2021 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of...
Cannalogue Expands Compassionate Care Program to Provide Lowest Medical Cannabis Price in Canada
Starting 4/20, online medical CBD supplier will offer dried flower at $1.96/gramTORONTO, April 07, 2021 (GLOBE NEWSWIRE) -- Doctor recommended...
Immutep Announces European Patent Grant For LAG525 Antibody In Combination Therapy
Sydney, AUSTRALIA, April 07, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a biotechnology...
Allena Pharmaceuticals Appoints Mark J. Fitzpatrick to its Board of Directors
NEWTON, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage biopharmaceutical company dedicated to developing...
Vincerx Pharma To Host Key Opinion Leader Webinar on Bioconjugation and CDK9 Inhibitors for the Treatment of Hematologic and Solid Tumors
PALO ALTO, Calif., April 07, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address...
Arch Oncology Appoints Laurence Blumberg, M.D. President and CEO
BRISBANE, Calif. and ST. LOUIS, April 07, 2021 (GLOBE NEWSWIRE) -- Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on...
Cabaletta Bio to Present at the 20th Annual Needham Healthcare Conference
PHILADELPHIA, April 07, 2021 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery...
Mydecine Announces API-naming structure of Four Lead Candidates and Prepares for Pre-IND
DENVER, April 07, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’),...
Conformis, Inc. to Release First Quarter 2021 Financial Results on May 5, 2021
BILLERICA, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial...
Trevi Therapeutics to Present at 20th Annual Needham Virtual Healthcare Conference
NEW HAVEN, Conn., April 07, 2021 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on...
Midwestern Medical Center Signs New Contract for Streamline Health® eValuator™
Automated Coding Analysis for Inpatient and Outpatient Care ATLANTA, April 07, 2021 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ:...
Mydecine Announces Four Lead Novel Drug Candidates and Prepares for Pre-IND Meetings with the FDA and Health Canada To Prepare For Human Clinical
DENVER, April 07, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’),...
The European Commission Grants Marketing Authorization for New Subcutaneous Administration of TYSABRI® (natalizumab) to Treat Relapsing-Remitting Multiple Sclerosis
TYSABRI is a well-established high-efficacy treatment that now provides two routes of administration enabling flexibility to meet patients' individual preferences...
Aleafia Health Launches Everyday Cannabis Brand Divvy
Divvy by Sunday Market The new everyday cannabis brand. TORONTO, April 07, 2021 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX:...
Olema Oncology to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
SAN FRANCISCO, April 07, 2021 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” NASDAQ: OLMA), a clinical-stage biopharmaceutical...
Emerging Markets Report: The Mushroom Movement
An Emerging Markets Sponsored Commentary ORLANDO, Fla., April 07, 2021 (GLOBE NEWSWIRE) -- A short while ago we introduced our...